Patents by Inventor Sean N. Parker

Sean N. Parker has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • SPLIT RADIO TACTICAL DATA LINK TERMINAL
    Publication number: 20240089796
    Abstract: A Link 16 terminal. The Link 16 terminal includes a red enclave. The red enclave comprises a Link 16 radio. The Link 16 radio is configured to send commands to Link 16 modems. The commands specify time slots when operations in the commands should be performed by the Link 16 modems. The Link 16 terminal further includes a black enclave physically separated from the red enclave. The black enclave includes a Link 16 modem configured to receive commands from the Link 16 radio. The Link 16 terminal further includes a communication channel configured to facilitate communication between the red enclave and the black enclave. The Link 16 radio is configured to dynamically adjust when commands are sent to the Link 16 modem with respect to time slots specified in the commands based on latency between the Link 16 radio and the Link 16 modem.
    Type: Application
    Filed: September 7, 2023
    Publication date: March 14, 2024
    Inventors: Jon E. Stearn, Sean K. Parker, Charles A. Wolfe, Peter C. Camana, Stuart N. Shanken, Thomas J. Allen
  • Treatment of immunological disease using berberine nanoparticles
    Patent number: 11351157
    Abstract: The disclosure provides methods of treating immunological conditions, e.g., allergy, by administration of berberine nanoparticles.
    Type: Grant
    Filed: October 16, 2017
    Date of Patent: June 7, 2022
    Assignees: Icahn School of Medicine at Mount Sinai, Sean N. Parker Foundation
    Inventors: Xiu-Min Li, Changda Liu, Kamal Srivatava, Haiqiong Yu, Sean N Parker
  • Treatment of Immunological Disease Using Berberine Nanoparticles
    Publication number: 20200276172
    Abstract: The disclosure provides methods of treating immunological conditions, e.g., allergy, by administration of berberine nanoparticles.
    Type: Application
    Filed: October 16, 2017
    Publication date: September 3, 2020
    Inventors: Xiu-Min Li, Changda Liu, Kamal Srivatava, Haiqiong Yu, Sean N Parker
  • Supression of IgE production by compounds derived from traditional chinese medicine
    Patent number: 10500169
    Abstract: The present invention relates to compounds and formulations derived from traditional Chinese medicine for use for the treatment and/or mediation of food allergies, in particular peanut allergies in humans by altering the activity and/or production of IgE.
    Type: Grant
    Filed: September 17, 2015
    Date of Patent: December 10, 2019
    Assignees: Sean N. Parker Foundation
    Inventors: Xiu-Min Li, Nan Yang, Chaoyi Mao, Ying Song, Sean N. Parker